Methods of diagnosing and alleviating gadolinium toxicity

Details for Australian Patent Application No. 2007325674 (hide)

Owner CorMedix Inc.

Inventors Shah, Sudhir V.; Sundararaman, Swaminathan

Agent Peter Maxwell & Associates

Pub. Number AU-A-2007325674

PCT Pub. Number WO2008/066862

Priority 60/861,440 29.11.06 US

Filing date 29 November 2007

Wipo publication date 5 June 2008

International Classifications

A61B 5/00 (2006.01) Measuring for diagnostic purposes

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 38/02 (2006.01) Medicinal preparations containing peptides - Peptides of undefined number of amino acids

A61P 39/04 (2006.01) General protective or antinoxious agents

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/066862 Priority application(s): WO2008/066862

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007325686-Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders

2007325652-Implant release mechanism